First human tests begin for new lung disease pill
NCT ID NCT07225296
Summary
This is an early-stage study to check the safety of a new oral drug called GNS-3545, which is being developed for a serious lung scarring disease called idiopathic pulmonary fibrosis (IPF). The study involves 72 healthy adult volunteers who will receive either the drug or a placebo to see how their bodies react to it. The main goal is to understand the drug's safety, how it moves through the body, and if food affects its absorption.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pharmaron CPC, Inc.
RECRUITINGBaltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.